Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych MEQs / SAQsAddiction psychiatry

Psych MEQs / SAQs · Addiction psychiatry

Addiction in older adults — late-onset alcohol and long-term benzodiazepine (MEQ)

FRANZCP-style MEQ on addiction in older adults: late-onset alcohol, BZD dependence, suicide/falls risk, pharmacotherapy doses, EMPOWER/Beers.

20 marks20 min
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
A 71-year-old woman is brought by her daughter after a fall. She has drunk half a bottle of wine most nights since her husband died 18 months ago, and has taken nitrazepam 5–10 mg at night for 9 years. She minimises both. Mini-Cog is borderline; GGT is raised; she has passive death wishes without a plan. She wants 'nothing changed' before her granddaughter's wedding next month. (i) Formulate early- vs late-onset and iatrogenic contributors and explain age-related vulnerability. (ii) Outline assessment including screens, risk (falls, suicide, capacity), and key investigations. (iii) Describe acute safety and withdrawal management principles. (iv) Construct a stepped definitive plan including SBIRT/psychosocial care, alcohol pharmacotherapy options with doses, and benzodiazepine deprescribing evidence. (v) Address prognosis and disposition. (20 marks)

Model answer

Reveal model answer

(i) Formulation and vulnerability. Late-onset (reactive) alcohol escalation after bereavement sits alongside long-term iatrogenic benzodiazepine exposure. Age-related lower lean mass/body water and higher CNS sensitivity raise alcohol and sedative effect per dose; polypharmacy and balance impairment drive falls. Do not require a young polysubstance stereotype to justify intervention.[1][2]

(ii) Assessment. Full alcohol quantity/frequency and last drink; actual nitrazepam dose/duration; AUDIT-C/SMAST-G; medication reconciliation; MSE; suicide risk (alcohol + late-life mood elevates risk); falls risk; cognition/capacity; collateral. Investigations: FBC/MCV, LFT/GGT, U&E, Mg, B12/folate, ECG if indicated; thiamine risk assessment.[1][2][7]

(iii) Acute safety. Do not abruptly stop nitrazepam or heavy alcohol before the wedding without a medical plan — withdrawal seizure/delirium risk. Stabilise, consider supervised reduction timing, falls precautions, thiamine if malnutrition/heavy use, and safety planning for passive death wishes.[1][7]

(iv) Definitive plan. Engage with non-stigmatising brief intervention/SBIRT principles (BRITE-style older-adult programmes). Treat grief/depression in parallel. After detox readiness: naltrexone 50 mg daily if opioid-free with LFT monitoring (Oslin older-adult adjunct evidence; COMBINE medical-management frame); acamprosate 666 mg TDS with renal adjustment as alternative/adjunct per product rules. Gradual BZD taper with EMPOWER-style education; Beers supports avoiding chronic BZD when possible; CBT-I/sleep strategies. Involve daughter as ally, not enforcer of cold turkey.[3][4][5][6][8]

(v) Prognosis/disposition. Older adults can improve with treatment; late-onset problems often respond when isolation and mood are addressed. Outpatient shared care if stable; step up to specialist addiction/old-age psychiatry or inpatient detox if high withdrawal risk, suicide risk, or failed community attempts.[2][1]

Common errors

  • Agreeing to change nothing because she is "not an alcoholic"
  • Abrupt BZD stop before a social event
  • No suicide assessment
  • No doses for naltrexone/acamprosate
  • Ignoring EMPOWER/Beers deprescribing evidence
[1] [6] [7]

Examiner notes

Full marks require phenotype language, PK/PD, screens, dual risk (falls + suicide), no cold turkey, named pharmacotherapy doses, and deprescribing evidence. Vague "refer to drug and alcohol" without a medical plan fails fellowship standard.[1][3]

References

  1. [1]Lehmann SW, Fingerhood M. Substance-Use Disorders in Later Life N Engl J Med, 2018.PMID 30575463
  2. [2]Kuerbis A, Sacco P, Blazer DG, et al. Substance abuse among older adults Clin Geriatr Med, 2014.PMID 25037298
  3. [3]Oslin D, Liberto JG, O'Brien J, et al. Naltrexone as an adjunctive treatment for older patients with alcohol dependence Am J Geriatr Psychiatry, 1997.PMID 9363289
  4. [4]Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study JAMA, 2006.PMID 16670409
  5. [5]Schonfeld L, King-Kallimanis BL, Duchene DM, et al. Screening and brief intervention for substance misuse among older adults: the Florida BRITE project Am J Public Health, 2010.PMID 19443821
  6. [6]Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial JAMA Intern Med, 2014.PMID 24733354
  7. [7]Blow FC, Brockmann LM, Barry KL. Role of alcohol in late-life suicide Alcohol Clin Exp Res, 2004.PMID 15166636
  8. [8]By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults J Am Geriatr Soc, 2023.PMID 37139824